Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation

Naoko Tsuyama, Seiji Sakata, Satoko Baba, Yuko Mishima, Noriko Nishimura, Kyoko Ueda, Masahiro Yokoyama, Yasuhito Terui, Kiyohiko Hatake, Masanobu Kitagawa, Naoki Ishizuka, Naoto Tomita, Kengo Takeuchi

Blood (2017) 130 (4): 489–500.

https://doi.org/10.1182/blood-2016-12-759621

Published: 2017

Includes: Supplemental data

Journal Articles

Azacitidin Is Effective in the Therapy Related Myelodysplastic Syndrome.

Hirofumi Yamauchi, MD, Masahiro Yokoyama, MD, Yuko Mishima, MD PhD, Noriko Nishimura, MD PhD, Kyoko Ueda, MD, Yoshiharu Kusano, MD, Norihito Inoue, MD, Anna Takahashi, MD, Yasuhito Terui, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2016) 128 (22): 5554.

https://doi.org/10.1182/blood.V128.22.5554.5554

Published: 2016

Journal Articles

Retrospective Analysis of NK/T Cell Lymphoma Prognostic Index (NKPI), EBV-DNA and Soluble IL-2 Receptor (sIL2R) for Extranodal NK/T-Cell Lymphoma, Nasal Type

Norihito Inoue, MD, Noriko Nishimura, MD PhD, Anna Takahashi, MD, Hirofumi Yamauchi, MD, Yoshiharu Kusano, MD, Kyoko Ueda, MD, Yuko Mishima, MD PhD, Masahiro Yokoyama, MD, Yasuhito Terui, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2016) 128 (22): 5360.

https://doi.org/10.1182/blood.V128.22.5360.5360

Published: 2016

Journal Articles

The Prognosis of PR Patients after Induction Therapy Was Not Inferior to CR in ASCT-Eligible NDMM Patient.

Anna Takahashi, MD, Yuko Mishima, MD PhD, Norihito Inoue, MD, Yoshiharu Kusano, MD, Hirofumi Yamauchi, MD, Kyoko Ueda, MD, Noriko Nishimura, MD PhD, Masahiro Yokoyama, MD, Yasuhito Terui, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2016) 128 (22): 5682.

https://doi.org/10.1182/blood.V128.22.5682.5682

Published: 2016

Journal Articles

Absolute CD4+ T-Cell Count Predicts Survival in Diffuse Large B-Cell Lymphoma

Yoshiharu Kusano, MD, Yasuhito Terui, MD PhD, Kengo Takeuchi, MD PhD, Anna Takahashi, MD, Norihito Inoue, MD, Hirohumi Yamauchi, MD, Naoko Tsuyama, MD, Kyoko Ueda, MD, Yuko Mishima, MD PhD, Noriko Nishimura, MD PhD, Masahiro Yokoyama, MD, Kiyohiko Hatake, MDPhD

Blood (2016) 128 (22): 3053.

https://doi.org/10.1182/blood.V128.22.3053.3053

Published: 2016

Journal Articles

R-CHOP Therapy Cannot Overcome CD5 Positive Non-GCB Subtype of DLBCL

Yuko Mishima, MD PhD, Masahiro Yokoyama, MD, Noriko Nishimura, MD PhD, Kyoko Ueda, MD, Tadahiro Gunji, MD, Hideaki Nitta, MD PhD, Yoshiharu Kusano, MD, Norihito Inoue, MD, Anna Takahashi, MD, Naoko Tsuyama, MD, Kengo Takeuchi, MDPhD, Yasuhito Terui, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 1507.

https://doi.org/10.1182/blood.V126.23.1507.1507

Published: 2015

Journal Articles

The Presence of M Protein Is Strongly Associated with Very Poor Prognosis in Patients with Extranodal Diffuse Large B-Cell Lymphoma

Hideaki Nitta, MD PhD, Yasuhito Terui, MD PhD, Masahiro Yokoyama, MD, Yuko Mishima, MD PhD, Noriko Nishimura, MD PhD, Kyoko Ueda, MD, Tadahiro Gunji, MD, Yoshiharu Kusano, MD, Norihito Inoue, MD, Anna Takahashi, MD, Naoko Tsuyama, MD, Kengo Takeuchi, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 5638.

https://doi.org/10.1182/blood.V126.23.5638.5638

Published: 2015

Journal Articles

Elevated CRP Is Associated with Longer Survival of PTCL-NOS in Peripheral T-Cell Lymphomas: A Single Institution Research

Tadahiro Gunji, MD, Yasuhito Terui, MD PhD, Anna Takahashi, MD, Norihito Inoue, MD, Yoshiharu Kusano, MD, Hideaki Nitta, MD PhD, Kyoko Ueda, MD, Noriko Nishimura, MD PhD, Yuko Mishima, MD PhD, Masahiro Yokoyama, MD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 5067.

https://doi.org/10.1182/blood.V126.23.5067.5067

Published: 2015

Journal Articles

Rituximab Maintenance Therapy Is an Effective Therapy in over-Sixties with Mantle Cell Lymphoma

Norihito Inoue, MD, Noriko Nishimura, MD PhD, Anna Takahashi, MD, Yoshiharu Kusano, MD, Tadahiro Gunji, MD, Hideaki Nitta, MD PhD, Kyoko Ueda, MD, Yuko Mishima, MD PhD, Masahiro Yokoyama, MD, Yasuhito Terui, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 5081.

https://doi.org/10.1182/blood.V126.23.5081.5081

Published: 2015

Journal Articles

80% Dose R-CHOP Is Suitable Chemotherapy for Very Elderly Patients with DLBCL

Anna Takahashi, MD, Yuko Mishima, MD PhD, Norihito Inoue, MD, Yoshiharu Kusano, MD, Tadahiro Gunji, MD, Kyoko Ueda, MD, Noriko Nishimura, MD PhD, Hideaki Nitta, MD PhD, Masahiro Yokoyama, MD, Naoko Tsuyama, MD, Kengo Takeuchi, MD PhD, Yasuhito Terui, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 5094.

https://doi.org/10.1182/blood.V126.23.5094.5094

Published: 2015

Journal Articles

Higher Titer of Epstein-Barr Virus Nuclear Antigen Might be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

Yoshiharu Kusano, MD, Yasuhito Terui, MD PhD, Kyoko Ueda, MD, Masahiro Yokoyama, MD, Noriko Nishimura, MD PhD, Yuko Mishima, MD PhD, Tadahiro Gunji, MD, Hideaki Nitta, MD PhD, Anna Takahasi, MD, Norihito Inoue, MD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 5013.

https://doi.org/10.1182/blood.V126.23.5013.5013

Published: 2015

Journal Articles

Higher Titer of Anti-EBV Nuclear Antigen Antibodies Might be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

Yoshiharu Kusano, MD, Yasuhito Terui, MD PhD, Kyoko Ueda, MD, Yuko Mishima, MD PhD, Noriko Nishimura, MD PhD, Masahiro Yokoyama, MD, Hideaki Nitta, MD PhD, Tadahiro Gunji, MD, Norihito Inoue, MD, Anna Takahasi, MD, Kengo Takeuchi, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 5016.

https://doi.org/10.1182/blood.V126.23.5016.5016

Published: 2015

Journal Articles

RT-DeVIC Therapy Is Effective for Localized NK/T Cell Lymphoma Patiens

Kyoko Ueda, MD, Noriko Nishimura, MD PhD, Yuko Mishima, MD PhD, Hideaki Nitta, MD, Yoshiharu Kusano, MD, Masahiro Yokoyama, MD, Naoko Tsuyama, Yasuhito Terui, MD PhD, Kengo Takeuchi, MD PhD, Oguchi Masahiko, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2014) 124 (21): 1702.

https://doi.org/10.1182/blood.V124.21.1702.1702

Published: 2014

Journal Articles

Serum Levels of CCL22 and CCL25 Might Predict Skin Rash Induction、the Common Adverse Event By Bendamustine Therapy in Malignant Lymphoma

Yasuhito Terui, MD PhD, Kyoko Ueda, MD, Yoshiharu Kusano, MD, Tadahiro Gunji, MD, Noriko Nishimura, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2014) 124 (21): 5427.

https://doi.org/10.1182/blood.V124.21.5427.5427

Published: 2014

Journal Articles

Is Radiation Therapy Effective for DLBCL As a Salvage after Chemotherapy?: A Study of 180 Diffuse Large B Cell Lymphoma (DLBCL) Cases at a Single Institution

Aya Ouchi, Yokoyama Masahiro, Masahiko Oguchi, MD, Kengo Takeuchi, MD PhD, Yoshiharu Kusano, MD, Hideaki Nitta, MD, Kyoko Ueda, MD, Noriko Nishimura, MD PhD, Naoko Tsuyama, MD, Yasuhito Terui, MD PhD, Noriko Usui, Keisuke Aiba, MD, PhD, Kiyohiko Hatake, MD PhD

Blood (2014) 124 (21): 5429.

https://doi.org/10.1182/blood.V124.21.5429.5429

Published: 2014

Journal Articles

ICE (Ifosfamide, carboplatin, and etoposide) Was the Best Salvage Regimen in Patients with Relapsed or Refractory Malignant Lymphoma

Yoshiharu Kusano, MD, Yasuhito Terui, MD PhD, Noriko Nishimura, MD PhD, Kyoko Ueda, MD, Gunji Tadahiro, MD, Hideaki Nitta, MD, Yuko Mishima, MD#12288;PhD, Masahiro Yokoyama, MD, Naoko Tsuyama, MD, Kengo Takeuchi, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2014) 124 (21): 5432.

https://doi.org/10.1182/blood.V124.21.5432.5432

Published: 2014

Journal Articles

Intrathecal Prophylaxis Might Be Required For Primary and Secondary Breast Lymphoma to prevent Central Nervous System Relapse

Yoshiharu Kusano, M.D, Noriko Nishimura, M.D., Ph D, Kyoko Ueda, M.D, Masahiro Yokoyama, M.D, Yasuhito Terui, M.D., Ph D, Kiyohiko Hatake, M.D., Ph D

Blood (2013) 122 (21): 5082.

https://doi.org/10.1182/blood.V122.21.5082.5082

Published: 2013

Journal Articles

Numbers and Percentages Of Peripheral Monocytes Is a Prognostic Marker For CNS Involvement In Diffuse Large B-Cell Lymphoma

Hideaki Nitta, M.D, Yasuhito Terui, M.D., PhD, Masahiro Yokoyama, M.D, Noriko Nishimura, M.D., PhD, Kyoko Ueda, M.D, Aya Ouchi, M.D, Naoko Tsuyama, M.D, Kengo Takeuchi, M.D., PhD, Kiyohiko Hatake, M.D., PhD

Blood (2013) 122 (21): 1775.

https://doi.org/10.1182/blood.V122.21.1775.1775

Published: 2013

Journal Articles

Ocular Adnexal Lymphomas (OALs) At Conjunctiva Present a Remarkable Good Prognosis : Oals Study Of 83 Cases At a Single Institution

Aya Ouchi, MD, Masahiro Yokoyama, M.D, Kenji Nakano, MD, Kengo Takeuchi, MD, PhD, Hideki Tsuji, Hideaki Nitta, M.D, Kyoko Ueda, M.D, Noriko Nishimura, M.D., Ph D, Naoko Tsuyama, M.D., Yasuhito Terui, M.D., Ph D, Kiyohiko Hatake, M.D., Ph D

Blood (2013) 122 (21): 4336.

https://doi.org/10.1182/blood.V122.21.4336.4336

Published: 2013

Journal Articles

Concurrent Radiotherapy and Dexamethasone, Etoposide, Ifosfamide, and Carboplatin (DeVIC) for Patients with Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Single Institution Analysis in Japan

Eriko Nara, MD, Masahiro Yokoyama, MD, Kengo Takeuchi, MD, Kenji Nakano, MD, Kyoko Ueda, MD, Noriko Nishimura, MD, PhD, Sakura Sakajiri, MD, Yuko Mishima, MD, Naoko Tsuyama, MD, Masahiko Oguchi, MD, Shunji Takahashi, MD, PhD, Yasuhito Terui, MD, PhD, Kiyohiko Hatake

Blood (2011) 118 (21): 1611.

https://doi.org/10.1182/blood.V118.21.1611.1611

Published: 2011

NARROW

BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation

Azacitidin Is Effective in the Therapy Related Myelodysplastic Syndrome.

Retrospective Analysis of NK/T Cell Lymphoma Prognostic Index (NKPI), EBV-DNA and Soluble IL-2 Receptor (sIL2R) for Extranodal NK/T-Cell Lymphoma, Nasal Type

The Prognosis of PR Patients after Induction Therapy Was Not Inferior to CR in ASCT-Eligible NDMM Patient.

Absolute CD4+ T-Cell Count Predicts Survival in Diffuse Large B-Cell Lymphoma

R-CHOP Therapy Cannot Overcome CD5 Positive Non-GCB Subtype of DLBCL

The Presence of M Protein Is Strongly Associated with Very Poor Prognosis in Patients with Extranodal Diffuse Large B-Cell Lymphoma

Elevated CRP Is Associated with Longer Survival of PTCL-NOS in Peripheral T-Cell Lymphomas: A Single Institution Research

Rituximab Maintenance Therapy Is an Effective Therapy in over-Sixties with Mantle Cell Lymphoma

80% Dose R-CHOP Is Suitable Chemotherapy for Very Elderly Patients with DLBCL

Higher Titer of Epstein-Barr Virus Nuclear Antigen Might be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

Higher Titer of Anti-EBV Nuclear Antigen Antibodies Might be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

RT-DeVIC Therapy Is Effective for Localized NK/T Cell Lymphoma Patiens

Serum Levels of CCL22 and CCL25 Might Predict Skin Rash Induction、the Common Adverse Event By Bendamustine Therapy in Malignant Lymphoma

Is Radiation Therapy Effective for DLBCL As a Salvage after Chemotherapy?: A Study of 180 Diffuse Large B Cell Lymphoma (DLBCL) Cases at a Single Institution

ICE (Ifosfamide, carboplatin, and etoposide) Was the Best Salvage Regimen in Patients with Relapsed or Refractory Malignant Lymphoma

Intrathecal Prophylaxis Might Be Required For Primary and Secondary Breast Lymphoma to prevent Central Nervous System Relapse

Numbers and Percentages Of Peripheral Monocytes Is a Prognostic Marker For CNS Involvement In Diffuse Large B-Cell Lymphoma

Ocular Adnexal Lymphomas (OALs) At Conjunctiva Present a Remarkable Good Prognosis : Oals Study Of 83 Cases At a Single Institution

Concurrent Radiotherapy and Dexamethasone, Etoposide, Ifosfamide, and Carboplatin (DeVIC) for Patients with Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Single Institution Analysis in Japan

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only